Moderna Inc. (MRNA)
NASDAQ: MRNA
· Real-Time Price · USD
25.14
0.86 (3.54%)
At close: Sep 05, 2025, 3:59 PM
25.07
-0.30%
After-hours: Sep 05, 2025, 07:57 PM EDT
Moderna Revenue Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Sales Revenue | 105M | 386M | 2.96B | 645M | 522M | 2.96B | 2.42B | 1B | 1.83B | 4.08B | 3.9B | 4.53B | 5.92B | n/a | 9.62B | 6.14B | 4.47B |
| Product Sales Revenue Growth | -72.80% | -86.98% | +359.53% | +23.56% | -82.34% | +22.11% | +142.00% | -45.30% | -55.19% | +4.59% | -13.93% | -23.53% | n/a | -100.00% | +56.47% | +37.56% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest Of The World Revenue | 55M | 308M | 324M | 22M | 67M | 979M | 741M | 231M | 1.25B | 1.61B | 1.09B | 1.69B | 2.9B | -644M | 3.61B | 2.1B | 375M |
| Rest Of The World Revenue Growth | -82.14% | -4.94% | +1372.73% | -67.16% | -93.16% | +32.12% | +220.78% | -81.53% | -22.44% | +47.98% | -35.54% | -41.77% | -550.93% | -117.82% | +71.72% | +461.07% | n/a |
| United States Revenue | 31M | 397M | 1.22B | 162M | 100M | 1.38B | 913M | 2M | 1M | 1.77B | 985M | 1.45B | 945M | 1.53B | 1.2B | 2.09B | 1.36B |
| United States Revenue Growth | -92.19% | -67.33% | +650.00% | +62.00% | -92.73% | +50.60% | +45550.00% | +100.00% | -99.94% | +79.70% | -32.07% | +53.44% | -38.19% | +27.74% | -42.81% | +54.12% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 230M | 212M | 351M | 281M | 268M | 274M | 470M | 442M | 332M | 305M | 375M | 278M | 211M | 268M | 201M | 168M | 121M | 77M | 78.99M | 48M | 37M | 24.11M | 25.63M | 28.19M | 28.52M | 27.28M | 38.02M | 18.52M | 21.39M | 16.32M | 15.9M | 16.73M | 16.04M | 16.04M |
| Selling, General, and Administrative Revenue Growth | +8.49% | -39.60% | +24.91% | +4.85% | -2.19% | -41.70% | +6.33% | +33.13% | +8.85% | -18.67% | +34.89% | +31.75% | -21.27% | +33.33% | +19.64% | +38.84% | +57.14% | -2.52% | +64.56% | +29.73% | +53.44% | -5.90% | -9.09% | -1.17% | +4.54% | -28.25% | +105.25% | -13.38% | +31.07% | +2.59% | -4.93% | +4.28% | 0.00% | n/a |
| Research and Development Revenue | 700M | 856M | 1.12B | 1.14B | 1.22B | 1.03B | 1.41B | 1.16B | 1.15B | 1.13B | 1.21B | 820M | 710M | 554M | 648M | 521M | 421M | 401M | 758.86M | 344.49M | 151.86M | 115.14M | 117.52M | 119.72M | 128.5M | 130.57M | 150.43M | 109.05M | 104.48M | 90.12M | 117.83M | 93.61M | 99.51M | 99.51M |
| Research and Development Revenue Growth | -18.22% | -23.71% | -1.32% | -6.88% | +18.89% | -26.96% | +21.21% | +1.05% | +1.50% | -6.61% | +47.68% | +15.49% | +28.16% | -14.51% | +24.38% | +23.75% | +4.99% | -47.16% | +120.29% | +126.85% | +31.89% | -2.03% | -1.83% | -6.83% | -1.59% | -13.20% | +37.94% | +4.38% | +15.93% | -23.51% | +25.87% | -5.93% | 0.00% | n/a |